Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial (CONCEPTT)
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Listed as NCT01788527, this NA trial focuses on Type 1 Diabetics Who Are Pregnant or Planning Pregnancy and remains completed. Sponsored by Cambridge University Hospitals NHS Foundation Trust, it has been updated 7 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Aug 2017 — Jun 2018 [monthly]
Completed NA
Phase: PHASE3 → NA
-
Jan 2017 — Aug 2017 [monthly]
Completed PHASE3
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cambridge University Hospitals NHS Foundation Trust
- Jaeb Center for Health Research
- Mount Sinai Hospital, Canada
- Sunnybrook Research Institute
- University of Cambridge
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aberdeen, United Kingdom , Barcelona, Spain , Calgary, Canada , Cambridge, United Kingdom , Dudley, United Kingdom , Edinburgh, United Kingdom , Galway, Ireland , Glasgow, United Kingdom , Halifax, Canada , Hamilton, Canada and 19 more locations